{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:41:29Z","timestamp":1761100889252,"version":"build-2065373602"},"reference-count":35,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":2809,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.bbmt.2007.04.003","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T08:54:55Z","timestamp":1180083295000},"page":"905-912","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Hematopoietic Stem Cell Transplantation in Australia and New Zealand, 1992-2004"],"prefix":"10.1016","volume":"13","author":[{"given":"Ian","family":"Nivison-Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth F.","family":"Bradstock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony J.","family":"Dodds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia A.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David D.F.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judy M.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeff","family":"Szer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2004","series-title":"Clinical Bone Marrow and Blood Stem Cell Transplantation","author":"Atkinson","key":"10.1016\/j.bbmt.2007.04.003_bib1"},{"key":"10.1016\/j.bbmt.2007.04.003_bib2","first-page":"649","article-title":"Transplant registries: guiding clinical decisions and improving outcomes","volume":"15","author":"Horowitz","year":"2001","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.bbmt.2007.04.003_bib3","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/sj.bmt.1705377","article-title":"EBMT activity survey 2004 and changes in disease indication over the past 15 years","volume":"37","author":"Gratwohl","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 1","key":"10.1016\/j.bbmt.2007.04.003_bib4","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/BF03165290","article-title":"The role of the EBMT activity survey in the management of hematopoietic stem cell transplantation","volume":"76","author":"Gratwohl","year":"2002","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2007.04.003_bib5","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s00277-004-1003-3","article-title":"Long-term results of autologous stem cell transplantation for Hodgkin\u2019s disease (HD) and low-\/intermediate-grade B non-Hodgkin\u2019s lymphoma (NHL): a report from the Austrian Stem Cell Transplantation Registry (ASCTR)","volume":"84","author":"Nachbaur","year":"2005","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2007.04.003_bib6","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1046\/j.1365-2141.2003.04793.x","article-title":"The use of a national transplant registry to benchmark transplant outcome for patients undergoing autologous and allogeneic stem cell transplantation in the United Kingdom and Ireland","volume":"124","author":"Russell","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2007.04.003_bib7","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s002770000194","article-title":"Transplant activities in Germany in 1998\u2014a survey facilitated by the National Registry for Hemopoietic Stem Cell Transplantation","volume":"79","author":"Ottinger","year":"2000","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2007.04.003_bib8","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/sj.bmt.1705148","article-title":"Myeloablative allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: significant roles of total body irradiation and chronic graft-versus-host disease","volume":"36","author":"Yanada","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.04.003_bib9","first-page":"1339","article-title":"Allogeneic stem cell transplantation for patients with acute myeloid leukemia or myelodysplastic syndrome who have chromosome 5 and\/or 7 abnormalities","volume":"90","author":"van der Straaten","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2007.04.003_bib10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4414\/smw.2006.11286","article-title":"Haematopoietic stem cell transplantation in Switzerland","volume":"136","author":"Passweg","year":"2006","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.bbmt.2007.04.003_bib11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1445-5994.2004.00704.x","article-title":"Haemopoietic stem cell transplantation in Australia and New Zealand, 1992-2001: progress report from the Australasian Bone Marrow Transplant Recipient Registry","volume":"35","author":"Nivison-Smith","year":"2005","journal-title":"Intern Med J"},{"year":"2006","series-title":"Population by Age and Sex, Australian States and Territories 3201.0","key":"10.1016\/j.bbmt.2007.04.003_bib12"},{"year":"2006","series-title":"Demographic Trends","key":"10.1016\/j.bbmt.2007.04.003_bib13"},{"year":"1996","series-title":"Analysing Survival Data from Clinical Trials and Observational Studies","author":"Marubini","key":"10.1016\/j.bbmt.2007.04.003_bib14"},{"key":"10.1016\/j.bbmt.2007.04.003_bib15","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.bbmt.2006.05.015","article-title":"Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation","volume":"12","author":"Artz","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.04.003_bib16","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/sj.bmt.1705366","article-title":"High-dose chemotherapy and autologous hematopoietic stem cell transplantation for metastatic breast cancer: a therapy whose time has passed","volume":"37","author":"Vogl","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.04.003_bib17","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJM200004133421501","article-title":"Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer","volume":"342","author":"Stadtmauer","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2007.04.003_bib18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/107327480301000105","article-title":"High-dose chemotherapy for breast cancer: the French PEGASE experience","volume":"10","author":"Roche","year":"2003","journal-title":"Cancer Control"},{"key":"10.1016\/j.bbmt.2007.04.003_bib19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejca.2004.09.006","article-title":"High-dose chemotherapy with haematopoietic stem cell transplantation for metastatic breast cancer patients: final results of the French multicentric randomised CMA\/PEGASE 04 protocol","volume":"41","author":"Lotz","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bbmt.2007.04.003_bib20","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/sj.bmt.1705367","volume":"37","author":"Vredenburgh","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 2","key":"10.1016\/j.bbmt.2007.04.003_bib21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF03165116","article-title":"Treatment of chronic myeloid leukaemia: lessons and challenges","volume":"76","author":"Goldman","year":"2002","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2007.04.003_bib22","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev.med.53.082901.103853","article-title":"Recent advancements in the treatment of chronic myelogenous leukemia","volume":"53","author":"O\u2019Dwyer","year":"2002","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.bbmt.2007.04.003_bib23","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/sj.bmt.1701234","article-title":"Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicenter trial of the European Group for Blood and Marrow Transplantation","volume":"21","author":"Schmitz","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.04.003_bib24","first-page":"3702","article-title":"Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation","volume":"95","author":"Champlin","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2007.04.003_bib25","first-page":"643","article-title":"Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial","volume":"90","author":"Schmitz","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2007.04.003_bib26","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/sj.bmt.1703535","article-title":"Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe","volume":"29","author":"Urbano-Ispizua","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2007.04.003_bib27","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1200\/JCO.2002.11.088","article-title":"Role of nonmyeloablative allogeneic stem-cell transplantation after failure of autologous transplantation in patients with lymphoproliferative malignancies","volume":"20","author":"Branson","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2007.04.003_bib28","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00001432-200208000-00001","article-title":"Infectious risks and outcomes after stem cell transplantation: are nonmyeloablative transplants changing the picture?","volume":"15","author":"Junghanss","year":"2002","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.bbmt.2007.04.003_bib29","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/(SICI)1097-0142(19971001)80:7<1273::AID-CNCR13>3.0.CO;2-4","article-title":"Cancer burden in the aged: an epidemiologic and demographic overview","volume":"80","author":"Yancik","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2007.04.003_bib30","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1002\/cncr.10593","article-title":"Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden","volume":"94","author":"Edwards","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2007.04.003_bib31","first-page":"965","article-title":"Allogeneic hematopoietic stem cell transplantation in patients 50 years of age and older","volume":"87","author":"de la Camara","year":"2002","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2007.04.003_bib32","first-page":"852","article-title":"A non-myeloablative conditioning regimen in allogeneic stem cell transplantation from related and unrelated donors in elderly patients","volume":"91","author":"Tsirigotis","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2007.04.003_bib33","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/01.tp.0000226171.43943.d3","article-title":"Costs of allogeneic hematopoietic stem cell transplantation","volume":"82","author":"Svahn","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2007.04.003_bib34","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1097\/01.tp.0000210324.44633.b1","article-title":"Treatment costs and survival in patients with grades III-IV acute graft-versus-host disease after allogenic hematopoietic stem cell transplantation during three decades","volume":"81","author":"Svahn","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2007.04.003_bib35","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/sj.bmt.1705478","article-title":"Clinical outcomes and direct hospital costs of reduced-intensity allogeneic transplantation in chronic myeloid leukemia","volume":"38","author":"Krejci","year":"2006","journal-title":"Bone Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879107002406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879107002406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:30:24Z","timestamp":1761057024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879107002406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S1083879107002406"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2007.04.003","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2007,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hematopoietic Stem Cell Transplantation in Australia and New Zealand, 1992-2004","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2007.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}